Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.295
+0.035 (2.78%)
Jul 16, 2025, 11:06 AM - Market open
Geron Employees
Geron had 229 employees as of December 31, 2024. The number of employees increased by 88 or 62.41% compared to the previous year.
Employees
229
Change (1Y)
88
Growth (1Y)
62.41%
Revenue / Employee
$507,830
Profits / Employee
-$607,061
Market Cap
824.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GERN News
- 27 days ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Conservative Vision Of A Positive Future For Geron - Seeking Alpha
- 7 weeks ago - Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program - Business Wire
- 2 months ago - Geron: Rytelo's Limited Adoption And Flat Demand Signal Troubled Outlook (Rating Downgrade) - Seeking Alpha
- 2 months ago - GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm - Business Wire
- 2 months ago - Geron Corporation (GERN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 12, 2025 in Geron Lawsuit – GERN - GlobeNewsWire
- 2 months ago - Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights - Business Wire